Get the Weekly Intelligence Brief — top committee picks every Sunday.

HOMB vs MSCI

Home BancShares vs MSCI Inc. — AI-powered side-by-side comparison
HOMB
Home BancShares
68
Buy
VS
MSCI
MSCI Inc.
56
Buy
MetricHOMBMSCI
AI Score 68 56
Price $29.80 $566.11
P/E Ratio 12.32× 31.43×
ROE 11.1% -45.3%
Revenue Growth YoY
Gross Margin 78.5% 83.0%
Debt / Equity 0.20× -2.43×
Dividend Yield 2.9% 1.4%
RSI (14) 27.9 53.6
Beta 0.676 1.222
Expected Upside +1.1% +1.0%

AI Committee View

Current Innellis committee reasoning for HOMB versus MSCI.
HOMB leads by 12 points.

HOMB scores 68/100 (Buy) versus MSCI at 56/100 (Buy).

HOMB Committee View
80% agreement
5 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
MSCI Committee View
50% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — high leverage (debt-to-equity 5.18) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 108.7% shows genuine earnings power backing the valuation — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • P/E of 29.9 is moderate-to-rich — Value
  • Price-to-book of 28.7x prices in significant intangible value — Value
  • Debt-to-equity of 5.18 adds balance-sheet risk to the value case — Value
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HOMB Full Analysis MSCI Full Analysis